Global Biologics Drug Development Market Growth (Status and Outlook) 2025-2031

September 2025 | 88 pages | ID: GFE4AFF1E7EEN
LP Information

Abstracts

According to this study, the global Biologics Drug Development market size will reach US$ million by 2031.

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Biologics Drug Development Industry Forecast” looks at past sales and reviews total world Biologics Drug Development sales in 2024, providing a comprehensive analysis by region and market sector of projected Biologics Drug Development sales for 2025 through 2031. With Biologics Drug Development sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics Drug Development industry.

This Insight Report provides a comprehensive analysis of the global Biologics Drug Development landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologics Drug Development portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologics Drug Development market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics Drug Development and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics Drug Development.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologics Drug Development market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Clinical Manufacturing
• Formulation Development
• Bioassay Development
• Analytical Services

Segmentation by Application:

• In-House
• Outsource
• Pharma Excess

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbvie
• Allergan
• Boehringer Ingelheim
• Charles River Laboratories
• Catalent
• Lonza Group
• Amgen
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biologics Drug Development Market Size (2020-2031)
  2.1.2 Biologics Drug Development Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Biologics Drug Development by Country/Region (2020, 2024 & 2031)
2.2 Biologics Drug Development Segment by Type
  2.2.1 Clinical Manufacturing
  2.2.2 Formulation Development
  2.2.3 Bioassay Development
  2.2.4 Analytical Services
2.3 Biologics Drug Development Market Size by Type
  2.3.1 Biologics Drug Development Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Biologics Drug Development Market Size Market Share by Type (2020-2025)
2.4 Biologics Drug Development Segment by Application
  2.4.1 In-House
  2.4.2 Outsource
  2.4.3 Pharma Excess
2.5 Biologics Drug Development Market Size by Application
  2.5.1 Biologics Drug Development Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Biologics Drug Development Market Size Market Share by Application (2020-2025)

3 BIOLOGICS DRUG DEVELOPMENT MARKET SIZE BY PLAYER

3.1 Biologics Drug Development Market Size Market Share by Player
  3.1.1 Global Biologics Drug Development Revenue by Player (2020-2025)
  3.1.2 Global Biologics Drug Development Revenue Market Share by Player (2020-2025)
3.2 Global Biologics Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOLOGICS DRUG DEVELOPMENT BY REGION

4.1 Biologics Drug Development Market Size by Region (2020-2025)
4.2 Global Biologics Drug Development Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biologics Drug Development Market Size Growth (2020-2025)
4.4 APAC Biologics Drug Development Market Size Growth (2020-2025)
4.5 Europe Biologics Drug Development Market Size Growth (2020-2025)
4.6 Middle East & Africa Biologics Drug Development Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Biologics Drug Development Market Size by Country (2020-2025)
5.2 Americas Biologics Drug Development Market Size by Type (2020-2025)
5.3 Americas Biologics Drug Development Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biologics Drug Development Market Size by Region (2020-2025)
6.2 APAC Biologics Drug Development Market Size by Type (2020-2025)
6.3 APAC Biologics Drug Development Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biologics Drug Development Market Size by Country (2020-2025)
7.2 Europe Biologics Drug Development Market Size by Type (2020-2025)
7.3 Europe Biologics Drug Development Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biologics Drug Development by Region (2020-2025)
8.2 Middle East & Africa Biologics Drug Development Market Size by Type (2020-2025)
8.3 Middle East & Africa Biologics Drug Development Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOLOGICS DRUG DEVELOPMENT MARKET FORECAST

10.1 Global Biologics Drug Development Forecast by Region (2026-2031)
  10.1.1 Global Biologics Drug Development Forecast by Region (2026-2031)
  10.1.2 Americas Biologics Drug Development Forecast
  10.1.3 APAC Biologics Drug Development Forecast
  10.1.4 Europe Biologics Drug Development Forecast
  10.1.5 Middle East & Africa Biologics Drug Development Forecast
10.2 Americas Biologics Drug Development Forecast by Country (2026-2031)
  10.2.1 United States Market Biologics Drug Development Forecast
  10.2.2 Canada Market Biologics Drug Development Forecast
  10.2.3 Mexico Market Biologics Drug Development Forecast
  10.2.4 Brazil Market Biologics Drug Development Forecast
10.3 APAC Biologics Drug Development Forecast by Region (2026-2031)
  10.3.1 China Biologics Drug Development Market Forecast
  10.3.2 Japan Market Biologics Drug Development Forecast
  10.3.3 Korea Market Biologics Drug Development Forecast
  10.3.4 Southeast Asia Market Biologics Drug Development Forecast
  10.3.5 India Market Biologics Drug Development Forecast
  10.3.6 Australia Market Biologics Drug Development Forecast
10.4 Europe Biologics Drug Development Forecast by Country (2026-2031)
  10.4.1 Germany Market Biologics Drug Development Forecast
  10.4.2 France Market Biologics Drug Development Forecast
  10.4.3 UK Market Biologics Drug Development Forecast
  10.4.4 Italy Market Biologics Drug Development Forecast
  10.4.5 Russia Market Biologics Drug Development Forecast
10.5 Middle East & Africa Biologics Drug Development Forecast by Region (2026-2031)
  10.5.1 Egypt Market Biologics Drug Development Forecast
  10.5.2 South Africa Market Biologics Drug Development Forecast
  10.5.3 Israel Market Biologics Drug Development Forecast
  10.5.4 Turkey Market Biologics Drug Development Forecast
10.6 Global Biologics Drug Development Forecast by Type (2026-2031)
10.7 Global Biologics Drug Development Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Biologics Drug Development Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbvie
  11.1.1 Abbvie Company Information
  11.1.2 Abbvie Biologics Drug Development Product Offered
  11.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbvie Main Business Overview
  11.1.5 Abbvie Latest Developments
11.2 Allergan
  11.2.1 Allergan Company Information
  11.2.2 Allergan Biologics Drug Development Product Offered
  11.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Allergan Main Business Overview
  11.2.5 Allergan Latest Developments
11.3 Boehringer Ingelheim
  11.3.1 Boehringer Ingelheim Company Information
  11.3.2 Boehringer Ingelheim Biologics Drug Development Product Offered
  11.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Boehringer Ingelheim Main Business Overview
  11.3.5 Boehringer Ingelheim Latest Developments
11.4 Charles River Laboratories
  11.4.1 Charles River Laboratories Company Information
  11.4.2 Charles River Laboratories Biologics Drug Development Product Offered
  11.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Charles River Laboratories Main Business Overview
  11.4.5 Charles River Laboratories Latest Developments
11.5 Catalent
  11.5.1 Catalent Company Information
  11.5.2 Catalent Biologics Drug Development Product Offered
  11.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Catalent Main Business Overview
  11.5.5 Catalent Latest Developments
11.6 Lonza Group
  11.6.1 Lonza Group Company Information
  11.6.2 Lonza Group Biologics Drug Development Product Offered
  11.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Lonza Group Main Business Overview
  11.6.5 Lonza Group Latest Developments
11.7 Amgen
  11.7.1 Amgen Company Information
  11.7.2 Amgen Biologics Drug Development Product Offered
  11.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Amgen Main Business Overview
  11.7.5 Amgen Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Biologics Drug Development Product Offered
  11.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biologics Drug Development Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biologics Drug Development Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Clinical Manufacturing
Table 4. Major Players of Formulation Development
Table 5. Major Players of Bioassay Development
Table 6. Major Players of Analytical Services
Table 7. Biologics Drug Development Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Biologics Drug Development Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Biologics Drug Development Market Size Market Share by Type (2020-2025)
Table 10. Biologics Drug Development Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Biologics Drug Development Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Biologics Drug Development Market Size Market Share by Application (2020-2025)
Table 13. Global Biologics Drug Development Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Biologics Drug Development Revenue Market Share by Player (2020-2025)
Table 15. Biologics Drug Development Key Players Head office and Products Offered
Table 16. Biologics Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biologics Drug Development Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Table 21. Global Biologics Drug Development Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Biologics Drug Development Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Biologics Drug Development Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Biologics Drug Development Market Size Market Share by Country (2020-2025)
Table 25. Americas Biologics Drug Development Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Biologics Drug Development Market Size Market Share by Type (2020-2025)
Table 27. Americas Biologics Drug Development Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Biologics Drug Development Market Size Market Share by Application (2020-2025)
Table 29. APAC Biologics Drug Development Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Biologics Drug Development Market Size Market Share by Region (2020-2025)
Table 31. APAC Biologics Drug Development Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Biologics Drug Development Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Biologics Drug Development Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Biologics Drug Development Market Size Market Share by Country (2020-2025)
Table 35. Europe Biologics Drug Development Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Biologics Drug Development Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Biologics Drug Development Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Biologics Drug Development Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Biologics Drug Development Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biologics Drug Development
Table 41. Key Market Challenges & Risks of Biologics Drug Development
Table 42. Key Industry Trends of Biologics Drug Development
Table 43. Global Biologics Drug Development Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Biologics Drug Development Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Biologics Drug Development Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Biologics Drug Development Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Abbvie Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 48. Abbvie Biologics Drug Development Product Offered
Table 49. Abbvie Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Abbvie Main Business
Table 51. Abbvie Latest Developments
Table 52. Allergan Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 53. Allergan Biologics Drug Development Product Offered
Table 54. Allergan Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Boehringer Ingelheim Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 58. Boehringer Ingelheim Biologics Drug Development Product Offered
Table 59. Boehringer Ingelheim Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Boehringer Ingelheim Main Business
Table 61. Boehringer Ingelheim Latest Developments
Table 62. Charles River Laboratories Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 63. Charles River Laboratories Biologics Drug Development Product Offered
Table 64. Charles River Laboratories Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Charles River Laboratories Main Business
Table 66. Charles River Laboratories Latest Developments
Table 67. Catalent Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 68. Catalent Biologics Drug Development Product Offered
Table 69. Catalent Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Catalent Main Business
Table 71. Catalent Latest Developments
Table 72. Lonza Group Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 73. Lonza Group Biologics Drug Development Product Offered
Table 74. Lonza Group Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Lonza Group Main Business
Table 76. Lonza Group Latest Developments
Table 77. Amgen Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 78. Amgen Biologics Drug Development Product Offered
Table 79. Amgen Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. Sanofi Details, Company Type, Biologics Drug Development Area Served and Its Competitors
Table 83. Sanofi Biologics Drug Development Product Offered
Table 84. Sanofi Biologics Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biologics Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologics Drug Development Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biologics Drug Development Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biologics Drug Development Sales Market Share by Country/Region (2024)
Figure 8. Biologics Drug Development Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biologics Drug Development Market Size Market Share by Type in 2024
Figure 10. Biologics Drug Development in In-House
Figure 11. Global Biologics Drug Development Market: In-House (2020-2025) & ($ millions)
Figure 12. Biologics Drug Development in Outsource
Figure 13. Global Biologics Drug Development Market: Outsource (2020-2025) & ($ millions)
Figure 14. Biologics Drug Development in Pharma Excess
Figure 15. Global Biologics Drug Development Market: Pharma Excess (2020-2025) & ($ millions)
Figure 16. Global Biologics Drug Development Market Size Market Share by Application in 2024
Figure 17. Global Biologics Drug Development Revenue Market Share by Player in 2024
Figure 18. Global Biologics Drug Development Market Size Market Share by Region (2020-2025)
Figure 19. Americas Biologics Drug Development Market Size 2020-2025 ($ millions)
Figure 20. APAC Biologics Drug Development Market Size 2020-2025 ($ millions)
Figure 21. Europe Biologics Drug Development Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Biologics Drug Development Market Size 2020-2025 ($ millions)
Figure 23. Americas Biologics Drug Development Value Market Share by Country in 2024
Figure 24. United States Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Biologics Drug Development Market Size Market Share by Region in 2024
Figure 29. APAC Biologics Drug Development Market Size Market Share by Type (2020-2025)
Figure 30. APAC Biologics Drug Development Market Size Market Share by Application (2020-2025)
Figure 31. China Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 35. India Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Biologics Drug Development Market Size Market Share by Country in 2024
Figure 38. Europe Biologics Drug Development Market Size Market Share by Type (2020-2025)
Figure 39. Europe Biologics Drug Development Market Size Market Share by Application (2020-2025)
Figure 40. Germany Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 41. France Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Biologics Drug Development Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Biologics Drug Development Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Biologics Drug Development Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Biologics Drug Development Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 54. APAC Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 55. Europe Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 57. United States Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 58. Canada Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 59. Mexico Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 60. Brazil Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 61. China Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 62. Japan Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 63. Korea Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 65. India Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 66. Australia Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 67. Germany Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 68. France Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 69. UK Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 70. Italy Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 71. Russia Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 72. Egypt Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 73. South Africa Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 74. Israel Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 75. Turkey Biologics Drug Development Market Size 2026-2031 ($ millions)
Figure 76. Global Biologics Drug Development Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Biologics Drug Development Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Biologics Drug Development Market Size 2026-2031 ($ millions)